Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria gonorrhoeae Strain, Alberta, Canada, 2018
- PMID: 31407661
- PMCID: PMC6711210
- DOI: 10.3201/eid2509.190407
Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria gonorrhoeae Strain, Alberta, Canada, 2018
Abstract
In July 2018, a case of Neisseria gonorrhoeae associated with ceftriaxone treatment failure was identified in Alberta, Canada. We identified the isolate and nucleic acid amplification testing (NAAT) specimen as the ceftriaxone-resistant strain multilocus sequence type 1903/NG-MAST 3435/NG-STAR 233, originally identified in Japan (FC428), with the same penA 60.001 mosaic allele and genetic resistance determinants. Core single-nucleotide variant (SNV) analysis identified 13 SNVs between this isolate and FC428. Culture-independent surveillance by PCR for the A311V mutation in the penA allele and N. gonorrhoeae multiantigen sequence typing directly from NAAT transport media positive for N. gonorrhoeae by NAAT did not detect spread of the strain. We identified multiple sequence types not previously detected in Alberta by routine surveillance. This case demonstrates the benefit of using culture-independent methods to enhance detection, public health investigations, and surveillance to address this global threat.
Keywords: Alberta; Canada; Neisseria gonorrhoeae; antimicrobial resistance; azithromycin; bacteria; cefixime; ceftriaxone; cephalosporin; drug resistance; gonorrhea; molecular epidemiology; molecular typing; penicillin binding protein 2; treatment failure.
Figures
Similar articles
-
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80. doi: 10.1128/AAC.05760-11. Epub 2011 Dec 12. Antimicrob Agents Chemother. 2012. PMID: 22155830 Free PMC article.
-
Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.Sex Transm Dis. 2017 Jun;44(6):351-355. doi: 10.1097/OLQ.0000000000000603. Sex Transm Dis. 2017. PMID: 28499284
-
Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019.Emerg Microbes Infect. 2022 Dec;11(1):344-350. doi: 10.1080/22221751.2021.2011618. Emerg Microbes Infect. 2022. PMID: 34994305 Free PMC article.
-
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.Antimicrob Agents Chemother. 2013 Nov;57(11):5225-32. doi: 10.1128/AAC.01295-13. Epub 2013 Aug 12. Antimicrob Agents Chemother. 2013. PMID: 23939890 Free PMC article.
-
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4. Med Microbiol Immunol. 2020. PMID: 31802195 Free PMC article. Review.
Cited by
-
Emergence and evolution of mosaic penA-60 and penA-237 alleles in a Neisseria gonorrhoeae core genogroup that was historically susceptible to extended spectrum cephalosporins.Front Microbiol. 2024 Oct 1;15:1401303. doi: 10.3389/fmicb.2024.1401303. eCollection 2024. Front Microbiol. 2024. PMID: 39411431 Free PMC article.
-
Neisseria gonorrhoeae treatment failure to the recommended antibiotic regimen-Québec, Canada, 2015-19.J Antimicrob Chemother. 2024 Nov 4;79(11):3029-3040. doi: 10.1093/jac/dkae327. J Antimicrob Chemother. 2024. PMID: 39288011
-
Current alternative therapies for treating drug-resistant Neisseria gonorrhoeae causing ophthalmia neonatorum.Future Microbiol. 2024;19(7):631-647. doi: 10.2217/fmb-2023-0251. Epub 2024 Mar 21. Future Microbiol. 2024. PMID: 38512111 Review.
-
Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2021.Can Commun Dis Rep. 2023 Sep 1;49(9):388-397. doi: 10.14745/ccdr.v49i09a05. eCollection 2023 Sep 1. Can Commun Dis Rep. 2023. PMID: 38463902 Free PMC article.
-
Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2020.Can Commun Dis Rep. 2022 Nov 3;48(11-12):571-579. doi: 10.14745/ccdr.v48i1112a10. eCollection 2022 Nov 3. Can Commun Dis Rep. 2022. PMID: 38298531 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017. Atlanta: The Centers; 2018.
-
- European Centre for Disease Prevention and Control. Control. ECDC Annual epidemiological report for 2016. Stockholm: The Centre; 2018.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

